首页> 外文OA文献 >CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen

【2h】

CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen

机译：CYP2D6基因变体：与联合用他莫昔芬治疗的英国乳腺癌患者队列中的乳腺癌特异性存活相关

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jean E Abraham; Mel J Maranian; Kristy E Driver; Radka Platte; Bolot Kalmyrzaev; Caroline Baynes; Craig Luccarini; Mitul Shah; Susan Ingle; David Greenberg; Helena M Earl; Alison M Dunning; Paul DP Pharoah; Carlos Caldas;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen [J] . Jean E Abraham, Mel J Maranian, Kristy E Driver, Breast Cancer Research . 2010,第4期

机译：CYP2D6基因变体：与联合用他莫昔芬治疗的英国乳腺癌患者队列中的乳腺癌特异性存活相关
2. Re: CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women With Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial and Re: CYP2D6 and UGT2B7 Genotype and Risk of Recurrence in Tamoxifen-Treated Breast Cancer Patients [J] . Paul D. P. Pharoah Jean Abraham and Carlos Caldas Journal of the National Cancer Institute . 2012,第16期

机译：Re：CYP2D6基因型和他莫昔芬对内分泌反应性乳腺癌的绝经后妇女的反应：国际乳腺癌组织1-98试验和Re：CYP2D6和UGT2B7基因型与他莫昔芬治疗的乳腺癌患者的复发风险
3. Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: The breast international group 1-98 trial and Re: CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients [J] . PharoahP.D.P., AbrahamJ., CaldasC. Journal of the National Cancer Institute . 2012,第16期

机译：Re：CYP2D6基因型和他莫昔芬反应对绝经后内分泌反应性乳腺癌妇女的影响：乳腺癌国际组1-98试验和Re：CYP2D6和UGT2B7基因型与他莫昔芬治疗的乳腺癌患者的复发风险
4. Association of Multi-Drug Resistance-1 (MDR1) Gene Polymorphism with Leukocytopenia in Breast Cancer Patients treated with Chemotherapy [C] . Siti Syarifah, Tri Widyawati, Kamal B. Siregar, Public Health International Conference . 2017

机译：化疗治疗乳腺癌患者白细胞凋亡的多药抗性-1（MDR1）基因多态性的关联
5. Associations between serum vitamin D, genetic polymorphisms in the vitamin D pathway, and sarcopenia with overall and breast cancer-specific mortality in a cohort of breast cancer survivors. [D] . Villasenor, Adriana. 2011

机译：人群中的血清维生素D，维生素D途径的遗传多态性和肌肉减少症与乳腺癌幸存者的总体死亡率和乳腺癌特异性死亡率之间的关联。
6. CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen [O] . Jean E Abraham, Mel J Maranian, Kristy E Driver, 2010

机译：CYP2D6基因变体：与联合用他莫昔芬治疗的英国乳腺癌患者队列中的乳腺癌特异性存活相关
7. CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen [O] . Abraham Jean Elizabeth, Maranian Mel J, Driver Kristy E, 2011

机译：CYP2D6基因变体：与联合用他莫昔芬治疗的英国乳腺癌患者队列中的乳腺癌特异性存活相关

CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen

著录项

引文网络

相似文献

相关主题

期刊订阅